Additional Resources

High dosage of Rifampin for TB meningitis is a current reasonable practice strategy to optimize outcomes. Clinicians should consider an individual’s comorbidities (e.g., pre-existing liver disease, risk for toxicity) and drug-drug interactions when starting and modifying TB treatment. Additional adjunctive treatment to optimize TB meningitis therapy should be considered given the significant morbidity and mortality associated with this disease.

DOSING of RIFAMPIN in TB MENINGITIS_10_28_24

Previous: CTCA TB Testing of School Age Children Position Statement, 2012
This position statement was supported by the California Medical Association. (ResolutionProposed)
.

These guidance document below and to the right are not being updated. Some information may not be current. If you are looking for older guidance not posted below and to the right, contact us through the button below for assistance.

Skip to content